{"nctId":"NCT02271854","briefTitle":"A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness","startDateStruct":{"date":"2014-10"},"conditions":["Muscle Soreness"],"count":102,"armGroups":[{"label":"diclofenac sodium gel 1%","type":"EXPERIMENTAL","interventionNames":["Drug: Diclofenac sodium gel 1%","Drug: Placebo"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Diclofenac sodium gel 1%","Drug: Placebo"]}],"interventions":[{"name":"Diclofenac sodium gel 1%","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female subjects aged 18-35 years\n* Not engaged in regular lower extremity fitness activities in the past 6 months prior to screening\n* Willing to refrain from use of ice, heat and massage during the study\n* DOMS score ≥4 Pain at Rest (PAR) and a DOMS score ≥5 Pain on Walking (POW), with moderate or severe on categorical scale\n\nExclusion Criteria:\n\n* Pain medication \\& corticosteroids prior to randomization\n* Topical analgesic or anti-inflammatory treatment over the previous month\n* Body mass index of \\>32 kg/m2\n\nOther protocol-defined inclusion/exclusion criteria may apply","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"35 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Sum of Pain Intensity Differences Over 24 Hours After Initiating Treatment (SPID 24), Derived From POW.","description":"The primary efficacy outcome was the time-weighted SPID 24 (POW). Sum of pain intensity differences over 24 hours after initiating treatment (SPID 24) for the modified ITT population. SPID 24 derived from Pain on Walking (POW) scores assessed over 24 hours on a 0 (No pain) - 10 (Pain as bad as you can imagine) Numerical Rating Scale. SPID 24 was computed using the trapezoidal rule, i.e. Σ \\[T(i) - T(i-1)\\] x \\[((PID)(i-1) + PID(i))/2\\] in an obvious notation, where T(i) is nominal time and PID(i), the pain intensity difference at Time i, is the baseline pain intensity (PI) score - PI score at Time i.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.15","spread":"35.95"},{"groupId":"OG001","value":"54.83","spread":"37.04"}]}]}]},{"type":"SECONDARY","title":"Sum of Pain Intensity Differences Over 48 Hours After Initiating Treatment (SPID 48), Derived From POW.","description":"Sum of pain intensity differences over 48 hours after initiating treatment (SPID 48) (POW) was a secondary outcome.\n\nSum of pain intensity differences over 48 hours after initiating treatment (SPID 48) for the modified ITT population. SPID 48 derived from Pain on Walking (POW) scores assessed over 48 hours on a 0 (No pain) - 10 (Pain as bad as you can imagine) Numerical Rating Scale. SPID 48 was computed using the trapezoidal rule, i.e. Σ \\[T(i) - T(i-1)\\] x \\[((PID)(i-1) + PID(i))/2\\] in an obvious notation, where T(i) is nominal time and PID(i), the pain intensity difference at Time i, is the baseline pain intensity (PI) score - PI score at Time i.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"151.8","spread":"81.9"},{"groupId":"OG001","value":"160.84","spread":"83.15"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":[]}}}